PPARγ has been proposed to be closely involved in regulating the inflammatory states underlying many airway diseases [40], [41] and PPARγ agonists have been suggested as alternative anti-inflammatory therapeutics in asthma [42]. The gene discussed is PPARG; the disease is asthma.